Kimberly Ann Mace
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kimberly Ann Mace has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Matthew J. Hardman
Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, HU6 7RX, UK
4 shared publications Tanja Torbica
Division of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom
4 shared publicationsElahe Mahdipour
Faculty of Life Sciences,The Healing Foundation Centre, University of Manchester, Manchester, UK
3 shared publications- Holly Nicola Wilkinson
Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, HU6 7RX, UK
3 shared publications Kate Wicks
Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
3 shared publications- Anna M. Kotowska
School of Pharmacy, University of Nottingham, Nottingham, UK
2 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Elsevier in Acta Biomaterialia
Glycosaminoglycan-Induced Macrophage Reprogramming Orchestrates Pro-Regenerative Crosstalk with Fibroblasts
- 11 November 2026
- Published by Elsevier in Acta Biomaterialia
Open AccessGlycosaminoglycan-Induced Macrophage Reprogramming Orchestrates Pro-Regenerative Crosstalk with Fibroblasts
- Open Access
- 31 August 2026
- Published by Elsevier in SSRN Electronic Journal
Glycosaminoglycan-Induced Macrophage Reprogramming Orchestrates Pro-Regenerative Crosstalk with Fibroblasts
Macrophages and fibroblasts play central roles in coordinating inflammation and tissue repair, whilst dysregulation of macrophage-fibroblast crosstalk drives pathological outcomes such as chronic inflammation and fibrosis. Glycosaminoglycans (GAGs), key components of the extracellular matrix (ECM), interact with cytokines and growth factors that modulate macrophage polarisation and direct fibroblast activity, making them attractive candidates for developing immune-instructive biomaterials. However, the optimal GAG compositions that promote macrophage-mediated repair and fibroblast-driven ECM remodelling remain unclear. Here, we report an unbiased screening of 82 surface-adsorbed GAG combinations to identify candidates capable of modulating macrophage-fibroblast interactions. Leveraging cytokine profiling, surface marker immunostaining, gene expression, principal component analysis (PCA), and hierarchical clustering, we identified ’hit’ GAG combinations that induced distinct, non-canonical macrophage activation programmes characterised by coordinated inflammatory and regulatory signalling, alongside enhanced fibroblast proliferation. Shortlisted formulations were validated using expanded biological replication, orthogonal phenotypic, transcriptional and functional analyses, assessment in macrophage-fibroblast co-culture systems, and in an in vivo diabetic wound model. These data demonstrated that 'hit' GAG formulations modulated macrophage functional activation states, promoted collagen and ECM synthesis, facilitated vascular and lymphatic vessel formation, and accelerated wound closure. Complementary metabolomic profiling using OrbiSIMS and molecular formula prediction (MFP), revealed macrophage metabolic reprogramming as a potential mechanism underlying these pro-healing effects. Collectively, this study established an unbiased methodology for discovering immune-instructive GAGs in supporting pro-healing responses for potential wound-healing applications.Keywords: Glycosaminoglycans; Macrophage-fibroblast crosstalk; Immunomodulation; Diabetic wound healing; Combinatorial screening; OrbiSIMS metabolomics
- 31 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessGlycosaminoglycan-Induced Macrophage Reprogramming Orchestrates Pro-Regenerative Crosstalk with Fibroblasts
Macrophages and fibroblasts play central roles in coordinating inflammation and tissue repair, whilst dysregulation of macrophage-fibroblast crosstalk drives pathological outcomes such as chronic inflammation and fibrosis. Glycosaminoglycans (GAGs), key components of the extracellular matrix (ECM), interact with cytokines and growth factors that modulate macrophage polarisation and direct fibroblast activity, making them attractive candidates for developing immune-instructive biomaterials. However, the optimal GAG compositions that promote macrophage-mediated repair and fibroblast-driven ECM remodelling remain unclear. Here, we report an unbiased screening of 82 surface-adsorbed GAG combinations to identify candidates capable of modulating macrophage-fibroblast interactions. Leveraging cytokine profiling, surface marker immunostaining, gene expression, principal component analysis (PCA), and hierarchical clustering, we identified ’hit’ GAG combinations that induced distinct, non-canonical macrophage activation programmes characterised by coordinated inflammatory and regulatory signalling, alongside enhanced fibroblast proliferation. Shortlisted formulations were validated using expanded biological replication, orthogonal phenotypic, transcriptional and functional analyses, assessment in macrophage-fibroblast co-culture systems, and in an in vivo diabetic wound model. These data demonstrated that 'hit' GAG formulations modulated macrophage functional activation states, promoted collagen and ECM synthesis, facilitated vascular and lymphatic vessel formation, and accelerated wound closure. Complementary metabolomic profiling using OrbiSIMS and molecular formula prediction (MFP), revealed macrophage metabolic reprogramming as a potential mechanism underlying these pro-healing effects. Collectively, this study established an unbiased methodology for discovering immune-instructive GAGs in supporting pro-healing responses for potential wound-healing applications.Keywords: Glycosaminoglycans; Macrophage-fibroblast crosstalk; Immunomodulation; Diabetic wound healing; Combinatorial screening; OrbiSIMS metabolomics
- Open Access
- 26 June 2026
- Published by Elsevier in SSRN Electronic Journal
Material-driven modulation of inflammation and re-epithelialization in diabetic wounds by collagen-based dressings
Chronic wounds present significant healing challenges, particularly in patients with diabetes, where elevated glucose levels and persistent inflammation impair tissue repair. Collagen-based dressings have been widely used to modulate the wound environment; however, comparative in vivo studies of commercially available formulations remain limited. This study investigated how collagen-based and synthetic wound dressings influence diabetic wound healing in a murine model, with particular focus on granulation tissue formation and re-epithelialization, processes central to human wound repair. Thirty-six db/db female mice were used to compare four collagen-based dressings and one bioactive synthetic dressing against a non-bioactive synthetic polyethylene/polyethylene terephthalate control dressing. Wound healing outcomes, including length, granulation tissue formation, re-epithelialization, and inflammatory cell and cytokine profiles, were assessed. B-Col was associated with reduced wound length at day 7, whereas the Col-ORC family of dressings promoted increased granulation tissue formation and enhanced re-epithelialization. Collagen-based dressings elicited distinct inflammatory cell responses compared with the control, indicating differential modulation of the wound microenvironment. Taken together, these findings demonstrate that collagen-based dressings with similar biochemical composition can elicit divergent in vivo wound healing responses, underscoring the importance of material behavior and matrix dynamics, rather than composition alone, in guiding biomaterial performance in chronic wound environments.
- 26 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMaterial-driven modulation of inflammation and re-epithelialization in diabetic wounds by collagen-based dressings
Chronic wounds present significant healing challenges, particularly in patients with diabetes, where elevated glucose levels and persistent inflammation impair tissue repair. Collagen-based dressings have been widely used to modulate the wound environment; however, comparative in vivo studies of commercially available formulations remain limited. This study investigated how collagen-based and synthetic wound dressings influence diabetic wound healing in a murine model, with particular focus on granulation tissue formation and re-epithelialization, processes central to human wound repair. Thirty-six db/db female mice were used to compare four collagen-based dressings and one bioactive synthetic dressing against a non-bioactive synthetic polyethylene/polyethylene terephthalate control dressing. Wound healing outcomes, including length, granulation tissue formation, re-epithelialization, and inflammatory cell and cytokine profiles, were assessed. B-Col was associated with reduced wound length at day 7, whereas the Col-ORC family of dressings promoted increased granulation tissue formation and enhanced re-epithelialization. Collagen-based dressings elicited distinct inflammatory cell responses compared with the control, indicating differential modulation of the wound microenvironment. Taken together, these findings demonstrate that collagen-based dressings with similar biochemical composition can elicit divergent in vivo wound healing responses, underscoring the importance of material behavior and matrix dynamics, rather than composition alone, in guiding biomaterial performance in chronic wound environments.
- Top Cited PapersOpen Access
- 25 March 2026
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 6 (5)
Physicochemical and Mechanical Characterization of Commercial Collagen‐Based Wound Dressings
Chronic wounds pose a global challenge by increasing patient morbidity and healthcare costs. Collagen‐based dressings, a key category for treating recalcitrant wounds, offer multiple advantages; however, comparative data on their benefits are sparse. A synthetic non‐bioactive control (NB‐Ctrl), four collagen‐based wound dressings, and a bioactive synthetic dressing were examined representing key dressing categories across the United States (US) and European Union (EU) markets. The non‐bioactive control was selected for its lack of biological activity. The collagen dressings included a 100% bovine type I collagen dressing (B‐Col), a collagen–oxidized regenerated cellulose dressing (Col‐ORC), its antimicrobial counterpart (Col‐ORC‐Ag), and a collagen–alginate–cellulose composite (Col). TLC‐NOSF‐CL, a bioactive synthetic dressing widely used in Europe, was also analyzed. Dressings were characterized using Fourier transform infrared spectroscopy, computer tomography scanning, and tensile tests, focusing on moisture balance, absorption, flexibility, and conformability. Higher porosity correlates with significantly higher swelling ratio and moisture‐vapor transmission rate. All collagen‐based dressings exhibit increased elasticity when wet and under flow‐induced shear stress, aiding conformity to irregular wound beds. These findings reveal performance differences not evident from manufacturer data. Providing clinicians with comparative mechanical data may support cost‐effective evidence‐based decisions, and more tailored wound care.
- 25 March 2026
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 6 (5)
Top Cited PapersOpen AccessPhysicochemical and Mechanical Characterization of Commercial Collagen‐Based Wound Dressings
Chronic wounds pose a global challenge by increasing patient morbidity and healthcare costs. Collagen‐based dressings, a key category for treating recalcitrant wounds, offer multiple advantages; however, comparative data on their benefits are sparse. A synthetic non‐bioactive control (NB‐Ctrl), four collagen‐based wound dressings, and a bioactive synthetic dressing were examined representing key dressing categories across the United States (US) and European Union (EU) markets. The non‐bioactive control was selected for its lack of biological activity. The collagen dressings included a 100% bovine type I collagen dressing (B‐Col), a collagen–oxidized regenerated cellulose dressing (Col‐ORC), its antimicrobial counterpart (Col‐ORC‐Ag), and a collagen–alginate–cellulose composite (Col). TLC‐NOSF‐CL, a bioactive synthetic dressing widely used in Europe, was also analyzed. Dressings were characterized using Fourier transform infrared spectroscopy, computer tomography scanning, and tensile tests, focusing on moisture balance, absorption, flexibility, and conformability. Higher porosity correlates with significantly higher swelling ratio and moisture‐vapor transmission rate. All collagen‐based dressings exhibit increased elasticity when wet and under flow‐induced shear stress, aiding conformity to irregular wound beds. These findings reveal performance differences not evident from manufacturer data. Providing clinicians with comparative mechanical data may support cost‐effective evidence‐based decisions, and more tailored wound care.
- Open Access
- 1 November 2025
- Published by Springer Nature in Biogerontology
- Vol. 26 (6) , 1-22
Intrinsic changes in cell differentiation and identity drive impaired wound healing in aged female murine skin
Cellular and molecular mechanisms that drive a perturbed wound microenvironment and impaired healing in aged skin have not been fully delineated. To obtain a comprehensive understanding of cell-intrinsic changes acquired during ageing that impact early responses to injury, we performed single-cell RNA sequencing in young and aged intact female murine skin and wounds 3 days post-injury. We observed that substantial changes in the mean proportional distribution and transcriptomic state of skin resident subpopulations in aged, but not young, tissues accompany a global increase in basal inflammation. This is driven by an altered signalling environment leading to impaired keratinocyte differentiation, loss of fibroblast identity and defective macrophage function. Further, we show that ageing-induced changes in skin resident cells persist after injury, resulting in increased expression of senescence-related genes in wound fibroblasts and aberrant monocyte-to-macrophage transitioning coupled to an enhanced inflammatory signature and defective intercellular signalling in comparison to wounds in young mice. In summary, our data highlights a contribution of both cell-intrinsic changes and an altered tissue microenvironment to poor wound healing responses in aged mice.
- 1 November 2025
- Published by Springer Nature in Biogerontology
- Vol. 26 (6) , 1-22
Open AccessIntrinsic changes in cell differentiation and identity drive impaired wound healing in aged female murine skin
Cellular and molecular mechanisms that drive a perturbed wound microenvironment and impaired healing in aged skin have not been fully delineated. To obtain a comprehensive understanding of cell-intrinsic changes acquired during ageing that impact early responses to injury, we performed single-cell RNA sequencing in young and aged intact female murine skin and wounds 3 days post-injury. We observed that substantial changes in the mean proportional distribution and transcriptomic state of skin resident subpopulations in aged, but not young, tissues accompany a global increase in basal inflammation. This is driven by an altered signalling environment leading to impaired keratinocyte differentiation, loss of fibroblast identity and defective macrophage function. Further, we show that ageing-induced changes in skin resident cells persist after injury, resulting in increased expression of senescence-related genes in wound fibroblasts and aberrant monocyte-to-macrophage transitioning coupled to an enhanced inflammatory signature and defective intercellular signalling in comparison to wounds in young mice. In summary, our data highlights a contribution of both cell-intrinsic changes and an altered tissue microenvironment to poor wound healing responses in aged mice.
- Open Access
- 4 December 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (12) , 3129
circRNAs May Be Involved in Dysfunction of Neutrophils of Type 2 Diabetic Mice through Regulation of Specific miRNAs
Diabetes is known to delay wound healing, and this delay is attributed to prolonged inflammation. We found that microRNAs (miRNAs) might be involved in the dysfunction of diabetic-derived neutrophils, and dynamics of neutrophil and chronic inflammation might be initiated by miRNA-regulated genes. Moreover, studies of miRNA function in nephropathy have suggested that circular RNAs (circRNAs), which function as sponges of miRNA to regulate their expression, are potential biomarkers and new therapeutic targets for the diagnosis of diabetic nephropathy. Accordingly, to investigate the molecular mechanism of the regulation of inflammation in diabetic-derived neutrophils, we identified circRNAs in diabetic-derived neutrophils obtained from BKS.Cg-Dock7m +/+ Leprdb/J (Leprdb/db and Leprdb/+) mice using microarrays. Neutrophils from pooled bone marrow of three diabetic and three non-diabetic mice were isolated and total RNA was extracted. Microarray analysis was performed using the Arraystar Mouse Circular RNA Array. The results showed that three circRNAs were significantly increased and six circRNAs were significantly decreased in diabetic-derived neutrophils compared with non-diabetic-derived neutrophils. The expressions of some circRNAs in diabetic-derived neutrophils were more than double those in non-diabetic-derived neutrophils. The circRNAs contain binding sites of miRNAs, which were differentially expressed in diabetic-derived neutrophils. Our results suggest that circRNAs may be involved in the regulation of inflammation in diabetic-derived neutrophils.
- 4 December 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (12) , 3129
Open AccesscircRNAs May Be Involved in Dysfunction of Neutrophils of Type 2 Diabetic Mice through Regulation of Specific miRNAs
Diabetes is known to delay wound healing, and this delay is attributed to prolonged inflammation. We found that microRNAs (miRNAs) might be involved in the dysfunction of diabetic-derived neutrophils, and dynamics of neutrophil and chronic inflammation might be initiated by miRNA-regulated genes. Moreover, studies of miRNA function in nephropathy have suggested that circular RNAs (circRNAs), which function as sponges of miRNA to regulate their expression, are potential biomarkers and new therapeutic targets for the diagnosis of diabetic nephropathy. Accordingly, to investigate the molecular mechanism of the regulation of inflammation in diabetic-derived neutrophils, we identified circRNAs in diabetic-derived neutrophils obtained from BKS.Cg-Dock7m +/+ Leprdb/J (Leprdb/db and Leprdb/+) mice using microarrays. Neutrophils from pooled bone marrow of three diabetic and three non-diabetic mice were isolated and total RNA was extracted. Microarray analysis was performed using the Arraystar Mouse Circular RNA Array. The results showed that three circRNAs were significantly increased and six circRNAs were significantly decreased in diabetic-derived neutrophils compared with non-diabetic-derived neutrophils. The expressions of some circRNAs in diabetic-derived neutrophils were more than double those in non-diabetic-derived neutrophils. The circRNAs contain binding sites of miRNAs, which were differentially expressed in diabetic-derived neutrophils. Our results suggest that circRNAs may be involved in the regulation of inflammation in diabetic-derived neutrophils.
- Open Access
- 8 July 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 943159
Age-Related Alterations in Macrophage Distribution and Function Are Associated With Delayed Cutaneous Wound Healing
Ageing-related delays and dysregulated inflammation in wound healing are well-documented in both human and animal models. However, cellular and molecular changes underlying this impairment in healing progression are not fully understood. In this study, we characterised ageing-associated changes to macrophages in wounds of young and aged mice and investigated transcriptomic differences that may impact the progression of wound healing. Full-thickness wounds created on the dorsum of C57BL/6J young and aged mice were excised on Days 3 and 7 post-wounding for analysis by immunohistochemistry, flow cytometry, and RNA sequencing. Our data revealed that macrophages were significantly reduced in aged wounds in comparison to young. Functional transcriptomic analyses showed that macrophages from aged wounds exhibited significantly reduced expression of cell cycle, DNA replication, and repair pathway genes. Furthermore, we uncovered an elevated pro-inflammatory gene expression program in the aged macrophages correlated with poor inflammation resolution and excessive tissue damage observed in aged wounds. Altogether, our work provides insights into how poorly healing aged wounds are phenotypically defined by the presence of macrophages with reduced proliferative capacity and an exacerbated inflammatory response, both of which are pathways that can be targeted to improve healing in the elderly.
- 8 July 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 943159
Open AccessAge-Related Alterations in Macrophage Distribution and Function Are Associated With Delayed Cutaneous Wound Healing
Ageing-related delays and dysregulated inflammation in wound healing are well-documented in both human and animal models. However, cellular and molecular changes underlying this impairment in healing progression are not fully understood. In this study, we characterised ageing-associated changes to macrophages in wounds of young and aged mice and investigated transcriptomic differences that may impact the progression of wound healing. Full-thickness wounds created on the dorsum of C57BL/6J young and aged mice were excised on Days 3 and 7 post-wounding for analysis by immunohistochemistry, flow cytometry, and RNA sequencing. Our data revealed that macrophages were significantly reduced in aged wounds in comparison to young. Functional transcriptomic analyses showed that macrophages from aged wounds exhibited significantly reduced expression of cell cycle, DNA replication, and repair pathway genes. Furthermore, we uncovered an elevated pro-inflammatory gene expression program in the aged macrophages correlated with poor inflammation resolution and excessive tissue damage observed in aged wounds. Altogether, our work provides insights into how poorly healing aged wounds are phenotypically defined by the presence of macrophages with reduced proliferative capacity and an exacerbated inflammatory response, both of which are pathways that can be targeted to improve healing in the elderly.
- Open Access
- 14 December 2020
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 16 (12) , e1009162
HOX paralogs selectively convert binding of ubiquitous transcription factors into tissue-specific patterns of enhancer activation
Gene expression programs determine cell fate in embryonic development and their dysregulation results in disease. Transcription factors (TFs) control gene expression by binding to enhancers, but how TFs select and activate their target enhancers is still unclear. HOX TFs share conserved homeodomains with highly similar sequence recognition properties, yet they impart the identity of different animal body parts. To understand how HOX TFs control their specific transcriptional programsin vivo, we compared HOXA2 and HOXA3 binding profiles in the mouse embryo. HOXA2 and HOXA3 directly cooperate with TALE TFs and selectively target different subsets of a broad TALE chromatin platform. Binding of HOX and tissue-specific TFs convert low affinity TALE binding into high confidence, tissue-specific binding events, which bear the mark of active enhancers. We propose that HOX paralogs, alone and in combination with tissue-specific TFs, generate tissue-specific transcriptional outputs by modulating the activity of TALE TFs at selected enhancers.
- 14 December 2020
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 16 (12) , e1009162
Open AccessHOX paralogs selectively convert binding of ubiquitous transcription factors into tissue-specific patterns of enhancer activation
Gene expression programs determine cell fate in embryonic development and their dysregulation results in disease. Transcription factors (TFs) control gene expression by binding to enhancers, but how TFs select and activate their target enhancers is still unclear. HOX TFs share conserved homeodomains with highly similar sequence recognition properties, yet they impart the identity of different animal body parts. To understand how HOX TFs control their specific transcriptional programsin vivo, we compared HOXA2 and HOXA3 binding profiles in the mouse embryo. HOXA2 and HOXA3 directly cooperate with TALE TFs and selectively target different subsets of a broad TALE chromatin platform. Binding of HOX and tissue-specific TFs convert low affinity TALE binding into high confidence, tissue-specific binding events, which bear the mark of active enhancers. We propose that HOX paralogs, alone and in combination with tissue-specific TFs, generate tissue-specific transcriptional outputs by modulating the activity of TALE TFs at selected enhancers.
- Open Access
- 23 January 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (1) , e0227817
Tissue-resident macrophages can be generated de novo in adult human skin from resident progenitor cells during substance P-mediated neurogenic inflammation ex vivo
Besides monocyte (MO)-derived macrophages (MACs), self-renewing tissue-resident macrophages (trMACs) maintain the intracutaneous MAC pool in murine skin. Here, we have asked whether the same phenomenon occurs in human skin using organ-cultured, full-thickness skin detached from blood circulation and bone marrow. Skin stimulation ex vivo with the neuropeptide substance P (SP), mimicking neurogenic skin inflammation, significantly increased the number of CD68+MACs in the papillary dermis without altering intracutaneous MAC proliferation or apoptosis. Since intraluminal CD14+MOs were undetectable in the non-perfused dermal vasculature, new MACs must have differentiated from resident intracutaneous progenitor cells in human skin. Interestingly, CD68+MACs were often seen in direct cell-cell-contact with cells expressing both, the hematopoietic stem cell marker CD34 and SP receptor (neurokinin-1 receptor [NK1R]). These cell-cell contacts and CD34+cell proliferation were up-regulated in SP-treated skin samples. Collectively, our study provides the first evidence that resident MAC progenitors, from which mature MACs can rapidly differentiate within the tissue, do exist in normal adult human skin. That these NK1R+trMAC-progenitor cells quickly respond to a key stress-associated neuroinflammatory stimulus suggests that this may satisfy increased local MAC demand under conditions of wounding/stress.
- 23 January 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (1) , e0227817
Open AccessTissue-resident macrophages can be generated de novo in adult human skin from resident progenitor cells during substance P-mediated neurogenic inflammation ex vivo
Besides monocyte (MO)-derived macrophages (MACs), self-renewing tissue-resident macrophages (trMACs) maintain the intracutaneous MAC pool in murine skin. Here, we have asked whether the same phenomenon occurs in human skin using organ-cultured, full-thickness skin detached from blood circulation and bone marrow. Skin stimulation ex vivo with the neuropeptide substance P (SP), mimicking neurogenic skin inflammation, significantly increased the number of CD68+MACs in the papillary dermis without altering intracutaneous MAC proliferation or apoptosis. Since intraluminal CD14+MOs were undetectable in the non-perfused dermal vasculature, new MACs must have differentiated from resident intracutaneous progenitor cells in human skin. Interestingly, CD68+MACs were often seen in direct cell-cell-contact with cells expressing both, the hematopoietic stem cell marker CD34 and SP receptor (neurokinin-1 receptor [NK1R]). These cell-cell contacts and CD34+cell proliferation were up-regulated in SP-treated skin samples. Collectively, our study provides the first evidence that resident MAC progenitors, from which mature MACs can rapidly differentiate within the tissue, do exist in normal adult human skin. That these NK1R+trMAC-progenitor cells quickly respond to a key stress-associated neuroinflammatory stimulus suggests that this may satisfy increased local MAC demand under conditions of wounding/stress.